Association Between Use of Renin-Angiotensin System Antagonists and Mortality in Patients With Heart Failure and Preserved Ejection Fraction

Abstract

Among patients with heart failure and preserved ejection fraction, the use of RAS antagonists was associated with lower all-cause mortality.